Enhabit, Inc. (NYSE:EHAB) Stock Holdings Lowered by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC reduced its stake in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 40.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,150 shares of the company's stock after selling 58,814 shares during the period. Cubist Systematic Strategies LLC owned 0.17% of Enhabit worth $681,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Bridgeway Capital Management LLC increased its stake in Enhabit by 4.1% during the fourth quarter. Bridgeway Capital Management LLC now owns 366,003 shares of the company's stock worth $2,858,000 after acquiring an additional 14,327 shares during the last quarter. BNP Paribas Financial Markets acquired a new stake in Enhabit during the 4th quarter worth approximately $198,000. Ameriprise Financial Inc. raised its holdings in Enhabit by 10.9% in the fourth quarter. Ameriprise Financial Inc. now owns 651,425 shares of the company's stock valued at $5,088,000 after buying an additional 64,228 shares during the period. AREX Capital Management LP lifted its position in Enhabit by 2.0% during the fourth quarter. AREX Capital Management LP now owns 2,490,795 shares of the company's stock valued at $19,453,000 after buying an additional 48,874 shares in the last quarter. Finally, 8 Knots Management LLC grew its stake in Enhabit by 16.4% during the fourth quarter. 8 Knots Management LLC now owns 4,430,898 shares of the company's stock worth $34,605,000 after buying an additional 623,602 shares during the period.

Enhabit Stock Down 0.6%

Shares of EHAB stock traded down $0.06 during trading hours on Wednesday, reaching $10.55. The company had a trading volume of 38,350 shares, compared to its average volume of 458,828. The stock's fifty day simple moving average is $8.62 and its 200 day simple moving average is $8.25. The company has a market capitalization of $534.22 million, a P/E ratio of -4.56 and a beta of 1.61. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $10.79.

Enhabit (NYSE:EHAB - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.07 by $0.03. The company had revenue of $259.90 million for the quarter, compared to analyst estimates of $266.11 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. As a group, sell-side analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.